The Dow Jones index closed lower by over 20 points on Wednesday. Insider transactions can provide insights into a company’s trajectory and potential. For those intrigued by penny stocks, these transactions can be a valuable piece of the puzzle.
Let’s delve into a few intriguing insider trades concerning penny stocks. For more such insights, delve into Benzinga’s insider transactions platform.
OPKO Health
- The Deal: OPKO Health, Inc. OPK 10% stakeholder Frost Gamma
Investments Trust acquired a total of 500,000 shares at an average price of $0.99. The
transaction totaled approximately $496,150. - Recent Progress: On Feb. 27, OPKO Health released encouraging quarterly results.
- OPKO Health Operations: OPKO Health Inc is engaged in diverse biotechnology
endeavors focusing on pharmaceutical and diagnostic initiatives.
Immunic
- The Acquisition: Immunic, Inc. IMUX President
and CEO Daniel Vitt procured a total of 14,000 shares at an average price of $1.31. The
investment amounted to about $18,333. - Recent Developments: On Feb. 22, Immunic reported a narrower fourth-quarter loss
than expected. - Immunic’s Focus: Immunic Inc specializes in advancing a pipeline of oral
immunology treatments for chronic inflammatory and autoimmune conditions, including ulcerative
colitis, Crohn’s disease, multiple sclerosis, and psoriasis.
Fresh Tracks Therapeutics
- The Deal: Fresh Tracks Therapeutics, Inc. FRTX 10% owner
Exploration Capital, LLC acquired a total of 20,109 shares at an average price of $0.90.
The insider invested around $18,098 in the transaction. - Recent Performance: The company’s stock experienced a 6% decline over the past
month. - Fresh Tracks Therapeutics’ Mission: Fresh Tracks Therapeutics Inc is committed to
enriching patient lives through the innovation and delivery of distinctive prescription therapies.
Be sure to explore our premarket coverage here
